Heron Therapeutics | Resultat Før Skat

Pre Tax Profit Lave om Dato
Alnylam Pharmaceuticals USD -137687000 288.43M 2023-12
Amarin USD -18810000 895K 2023-09
ANI Pharmaceuticals USD 27.68M 10.91M 2023-06
Arrowhead Research USD -138689000 29.7M 2023-12
Eisai JPY 7.37B 20.91B 2023-09
GlaxoSmithKline GBP 2.62B 600M 2023-09
Insmed USD -185063000 26.67M 2023-12
Ligand Pharmaceuticals USD 22.37M 8.75M 2023-09
Neurocrine Biosciences USD 198.2M 82.6M 2023-12
Pacira USD 48.15M 121K 2023-09
Regeneron Pharmaceuticals USD 1.4B 54.4M 2023-12
Roche Holding CHF 10.33B 1.48B 2023-06
Ultragenyx Pharmaceutical USD -126892000 32.11M 2023-12
Veracyte USD -30472000 700K 2023-12
Vertex Pharmaceuticals USD 1.31B 9.6M 2023-12



Heron Therapeutics Resultat Før Skat - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - Apr 2024.